Protara Therapeutics Inc
TARA
NASDAQ
Biotechnology
$3.97
USD
+0.03 (+0.76%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $233.72M
Volume 332.9K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
CAPR | Capricor Therapeutics Inc | $252.50M | - | - | - | |
RCEL | AVITA Medical Inc | $251.13M | - | +1.0% | - | |
PYXS | Pyxis Oncology Inc | $242.65M | - | -14.2% | - | |
TARA | Protara Therapeutics Inc | $231.00M | - | - | - | |
ORGO | Organogenesis Holdings Inc | $230.97M | 84.95 | +12.2% | - | |
CAMP | CAMP4 Therapeutics Corp | $219.13M | - | +5.6% | - | |
KROS | Keros Therapeutics Inc | $208.98M | - | -93.5% | - | |
IVVD | Invivyd Inc | $198.30M | - | +52.3% | - | |
CNXU | Conexeu Sciences Inc | $194.53M | - | - | - |
Top Peer by Growth
Atrium Therapeutics Inc
+22.0% YoY Revenue
Lowest P/E Ratio
Organogenesis Holdings Inc
84.95x P/E
Best 1-Year Return
Immunic Inc
+100.0% Return